Table 1

Available PMCS systems

DeviceAccessMechanismLevel of supportAdvantagesLimitationsContraindicationsMajor complications
IABPPercutaneous or surgical 7.5–8FCounterpulsation (systolic unloading, diastolic augmentation)0.5 L/minKnow-how
Ease of use
Small diameter for access
Modest augmentation of CO
Uses ECG or BP triggers, not optimal for VT
Moderate to severe aortic regurgitation
Aortic valve disease
Severe PAD
Limb ischaemia
Renal or gut ischaemia
Vascular injury
Stroke
TandemHeartPercutaneous or surgical
21F inflow (transseptal)
15 or 17 F outflow
Centrifugal continuous flow pump3.5–5.0 L/minComplete LV supportLarge cannulas, requires TS accessSevere PAD
Ventricular septal defect
Severe RV failure
Limb ischaemia
Vascular injury
Tamponade
Stroke
Vascular injury
Residual ASD
Air embolism
Impella 2.5
Impella CP
Impella 5.0
Percutaneous or surgical
Single arterial access 13F
Percutaneous or surgical
Single arterial access 14F
Surgical cutdown
Single arterial access 21F
Axial flow pump
(pumping blood from LV to aorta)
2.5 L/min
3.5 L/min
5.0 L/min
Partial LV support
Partial LV support
Complete LV support
Large arterial cannula
Large arterial cannula
Large arterial cannula
Mechanical aortic valve
Aortic stenosis
Aortic valve disease
Moderate to severe aortic regurgitation
Severe PAD
LV thrombus
Ventricular septal defect
RV failure
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
VA ECMOPercutaneous or surgical
17–22F venous, 15F arterial
Centrifugal continuous flow pump with oxygenator>4.5 L/minHighest level of LV support
Usable in RV failure
Large cannulas
Complex setup
Severe PAD
Uncontrollable coagulopathy
Limb ischaemia
Vascular injury
Pulmonary oedema
Bleeding sepsis
Thrombus
Systemic embolism
DeviceAccessMechanismLevel of supportAdvantagesLimitationsContraindicationsMajor complications
IABPPercutaneous or surgical 7.5–8FCounterpulsation (systolic unloading, diastolic augmentation)0.5 L/minKnow-how
Ease of use
Small diameter for access
Modest augmentation of CO
Uses ECG or BP triggers, not optimal for VT
Moderate to severe aortic regurgitation
Aortic valve disease
Severe PAD
Limb ischaemia
Renal or gut ischaemia
Vascular injury
Stroke
TandemHeartPercutaneous or surgical
21F inflow (transseptal)
15 or 17 F outflow
Centrifugal continuous flow pump3.5–5.0 L/minComplete LV supportLarge cannulas, requires TS accessSevere PAD
Ventricular septal defect
Severe RV failure
Limb ischaemia
Vascular injury
Tamponade
Stroke
Vascular injury
Residual ASD
Air embolism
Impella 2.5
Impella CP
Impella 5.0
Percutaneous or surgical
Single arterial access 13F
Percutaneous or surgical
Single arterial access 14F
Surgical cutdown
Single arterial access 21F
Axial flow pump
(pumping blood from LV to aorta)
2.5 L/min
3.5 L/min
5.0 L/min
Partial LV support
Partial LV support
Complete LV support
Large arterial cannula
Large arterial cannula
Large arterial cannula
Mechanical aortic valve
Aortic stenosis
Aortic valve disease
Moderate to severe aortic regurgitation
Severe PAD
LV thrombus
Ventricular septal defect
RV failure
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
VA ECMOPercutaneous or surgical
17–22F venous, 15F arterial
Centrifugal continuous flow pump with oxygenator>4.5 L/minHighest level of LV support
Usable in RV failure
Large cannulas
Complex setup
Severe PAD
Uncontrollable coagulopathy
Limb ischaemia
Vascular injury
Pulmonary oedema
Bleeding sepsis
Thrombus
Systemic embolism

ASD, atrial septal defect; BP, blood pressure; CO, cardiac output; IABP, intra-aortic balloon pump; LV, left ventricular; PAD, peripheral artery disease; PMCS, percutaneous mechanical cardiac support; RV, right ventricular; VA ECMO, venoarterial extracorporeal membrane oxygenation; VT, ventricular tachycardia.

Table 1

Available PMCS systems

DeviceAccessMechanismLevel of supportAdvantagesLimitationsContraindicationsMajor complications
IABPPercutaneous or surgical 7.5–8FCounterpulsation (systolic unloading, diastolic augmentation)0.5 L/minKnow-how
Ease of use
Small diameter for access
Modest augmentation of CO
Uses ECG or BP triggers, not optimal for VT
Moderate to severe aortic regurgitation
Aortic valve disease
Severe PAD
Limb ischaemia
Renal or gut ischaemia
Vascular injury
Stroke
TandemHeartPercutaneous or surgical
21F inflow (transseptal)
15 or 17 F outflow
Centrifugal continuous flow pump3.5–5.0 L/minComplete LV supportLarge cannulas, requires TS accessSevere PAD
Ventricular septal defect
Severe RV failure
Limb ischaemia
Vascular injury
Tamponade
Stroke
Vascular injury
Residual ASD
Air embolism
Impella 2.5
Impella CP
Impella 5.0
Percutaneous or surgical
Single arterial access 13F
Percutaneous or surgical
Single arterial access 14F
Surgical cutdown
Single arterial access 21F
Axial flow pump
(pumping blood from LV to aorta)
2.5 L/min
3.5 L/min
5.0 L/min
Partial LV support
Partial LV support
Complete LV support
Large arterial cannula
Large arterial cannula
Large arterial cannula
Mechanical aortic valve
Aortic stenosis
Aortic valve disease
Moderate to severe aortic regurgitation
Severe PAD
LV thrombus
Ventricular septal defect
RV failure
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
VA ECMOPercutaneous or surgical
17–22F venous, 15F arterial
Centrifugal continuous flow pump with oxygenator>4.5 L/minHighest level of LV support
Usable in RV failure
Large cannulas
Complex setup
Severe PAD
Uncontrollable coagulopathy
Limb ischaemia
Vascular injury
Pulmonary oedema
Bleeding sepsis
Thrombus
Systemic embolism
DeviceAccessMechanismLevel of supportAdvantagesLimitationsContraindicationsMajor complications
IABPPercutaneous or surgical 7.5–8FCounterpulsation (systolic unloading, diastolic augmentation)0.5 L/minKnow-how
Ease of use
Small diameter for access
Modest augmentation of CO
Uses ECG or BP triggers, not optimal for VT
Moderate to severe aortic regurgitation
Aortic valve disease
Severe PAD
Limb ischaemia
Renal or gut ischaemia
Vascular injury
Stroke
TandemHeartPercutaneous or surgical
21F inflow (transseptal)
15 or 17 F outflow
Centrifugal continuous flow pump3.5–5.0 L/minComplete LV supportLarge cannulas, requires TS accessSevere PAD
Ventricular septal defect
Severe RV failure
Limb ischaemia
Vascular injury
Tamponade
Stroke
Vascular injury
Residual ASD
Air embolism
Impella 2.5
Impella CP
Impella 5.0
Percutaneous or surgical
Single arterial access 13F
Percutaneous or surgical
Single arterial access 14F
Surgical cutdown
Single arterial access 21F
Axial flow pump
(pumping blood from LV to aorta)
2.5 L/min
3.5 L/min
5.0 L/min
Partial LV support
Partial LV support
Complete LV support
Large arterial cannula
Large arterial cannula
Large arterial cannula
Mechanical aortic valve
Aortic stenosis
Aortic valve disease
Moderate to severe aortic regurgitation
Severe PAD
LV thrombus
Ventricular septal defect
RV failure
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
Limb ischaemia
Vascular injury
Perforation
Stroke
Haemolysis
VA ECMOPercutaneous or surgical
17–22F venous, 15F arterial
Centrifugal continuous flow pump with oxygenator>4.5 L/minHighest level of LV support
Usable in RV failure
Large cannulas
Complex setup
Severe PAD
Uncontrollable coagulopathy
Limb ischaemia
Vascular injury
Pulmonary oedema
Bleeding sepsis
Thrombus
Systemic embolism

ASD, atrial septal defect; BP, blood pressure; CO, cardiac output; IABP, intra-aortic balloon pump; LV, left ventricular; PAD, peripheral artery disease; PMCS, percutaneous mechanical cardiac support; RV, right ventricular; VA ECMO, venoarterial extracorporeal membrane oxygenation; VT, ventricular tachycardia.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close